RAC 2.92% $1.94 race oncology ltd

Ann: Compelling Preclinical Breast Cancer Results, page-18

  1. 286 Posts.
    lightbulb Created with Sketch. 33
    At this point, I would say these results indicate a good opportunity for big pharama to swoop in and buy RAC, especially with the success in breast cancer.

    Needless to say, we still have more transformative value to be extracted from this gold mine in FTO, so buckle up and enjoy the ride everyone!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.